T2 Biosystems Stock Price Prediction
| TTOO Stock | USD 0.01 0.01 50.00% |
Momentum 50
Impartial
Oversold | Overbought |
Using T2 Biosystems hype-based prediction, you can estimate the value of T2 Biosystems from the perspective of T2 Biosystems response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in T2 Biosystems to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying TTOO because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
T2 Biosystems after-hype prediction price | USD 0.00522 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TTOO |
T2 Biosystems After-Hype Price Prediction Density Analysis
As far as predicting the price of T2 Biosystems at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in T2 Biosystems or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of T2 Biosystems, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
T2 Biosystems Estimiated After-Hype Price Volatility
In the context of predicting T2 Biosystems' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on T2 Biosystems' historical news coverage. T2 Biosystems' after-hype downside and upside margins for the prediction period are 0.00 and 50.26, respectively. We have considered T2 Biosystems' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
T2 Biosystems is out of control at this time. Analysis and calculation of next after-hype price of T2 Biosystems is based on 3 months time horizon.
T2 Biosystems Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as T2 Biosystems is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading T2 Biosystems backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with T2 Biosystems, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
21.68 | 139.66 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 4.41 |
|
T2 Biosystems Hype Timeline
T2 Biosystems is at this time traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. TTOO is estimated to increase in value after the next headline, with the price projected to jump to 0.00522 or above. The average volatility of media hype impact on the company the price is insignificant. The price boost on the next news is estimated to be 4.41%, whereas the daily expected return is at this time at 21.68%. The volatility of related hype on T2 Biosystems is about 0.0%, with the expected price after the next announcement by competition of 0.01. T2 Biosystems currently holds about 13.21 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next estimated press release will be within a week. Check out T2 Biosystems Basic Forecasting Models to cross-verify your projections.T2 Biosystems Related Hype Analysis
Having access to credible news sources related to T2 Biosystems' direct competition is more important than ever and may enhance your ability to predict T2 Biosystems' future price movements. Getting to know how T2 Biosystems' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how T2 Biosystems may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TEVNF | Tevano Systems Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PDMI | Paradigm Medical Ind | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LFCOF | Lift Co Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MDIN | Northstar Global Business | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RASP | Rasna Therapeutics | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 87.50 | |
| IPIX | Innovation Pharmaceuticals | 0.00 | 0 per month | 22.51 | 0.18 | 110.00 | (52.38) | 1,087 | |
| AOXG | Aoxing Pharmaceutical | 0.00 | 0 per month | 14.31 | 0.12 | 78.18 | (40.00) | 138.93 | |
| CHNXF | ChitogenX | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GRVE | Groove Botanicals | 0.00 | 0 per month | 6.73 | 0.17 | 40.23 | (12.37) | 88.43 | |
| WSNAF | Wesana Health Holdings | 0.00 | 0 per month | 22.14 | 0.16 | 81.82 | (41.46) | 194.30 |
T2 Biosystems Additional Predictive Modules
Most predictive techniques to examine TTOO price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TTOO using various technical indicators. When you analyze TTOO charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About T2 Biosystems Predictive Indicators
The successful prediction of T2 Biosystems stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as T2 Biosystems, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of T2 Biosystems based on analysis of T2 Biosystems hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to T2 Biosystems's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to T2 Biosystems's related companies.
Story Coverage note for T2 Biosystems
The number of cover stories for T2 Biosystems depends on current market conditions and T2 Biosystems' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that T2 Biosystems is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about T2 Biosystems' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
T2 Biosystems Short Properties
T2 Biosystems' future price predictability will typically decrease when T2 Biosystems' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of T2 Biosystems often depends not only on the future outlook of the potential T2 Biosystems' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. T2 Biosystems' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.6 M | |
| Cash And Short Term Investments | 15.7 M |
Other Information on Investing in TTOO Pink Sheet
T2 Biosystems financial ratios help investors to determine whether TTOO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TTOO with respect to the benefits of owning T2 Biosystems security.